Haber E, Hui K Y, Carlson W D, Bernatowicz M S
Cardiac Unit, Massachusetts General Hospital, Boston 02114.
J Cardiovasc Pharmacol. 1987;10 Suppl 7:S54-8.
Principles for the design of renin inhibitors were examined by utilizing a three-dimensional model of the enzyme with inhibitory peptides in its catalytic site. Optimal conformations were subjected to energy minimization by the computer program CHARMM. The results were then compared with the inhibitory potencies of these peptides as assessed by an in vitro renin assay. The results of the modeling study and enzymatic assay were generally congruent, showing that residues at the P5, P4 and P3 positions contributed importantly to binding, that an acetyl group can replace Pro-His at the P5, P6 position, that the lesser potency of AHPPA-containing as compared with statine-containing peptides may be related to the better fit into the S1 subsite of an isobutyl as opposed to a benzyl side chain, that histidine in the P2 position forms an essential hydrogen bond with residue 230 (which cannot be formed by another basic residue), and that there is a general correlation between inhibitory potency and calculated energy of interaction as deduced from the model. Major determinants of energy of binding are conformational strain and electrostatic interaction.
通过利用肾素的三维模型(其催化位点含有抑制性肽)来研究肾素抑制剂的设计原则。通过计算机程序CHARMM对最佳构象进行能量最小化处理。然后将结果与通过体外肾素测定评估的这些肽的抑制效力进行比较。建模研究和酶促测定的结果总体上是一致的,表明P5、P4和P3位置的残基对结合有重要贡献,乙酰基可以取代P5、P6位置的脯氨酸-组氨酸,与含他汀的肽相比,含AHPPA的肽效力较低可能与异丁基而非苄基侧链更适合S1亚位点有关,P2位置的组氨酸与230位残基形成必需的氢键(另一个碱性残基无法形成),并且从模型推导得出,抑制效力与计算出的相互作用能量之间存在普遍相关性。结合能量的主要决定因素是构象应变和静电相互作用。